Risk factors
Co-Diagnostics (CODX) risk factors
Item 1A of every Co-Diagnostics, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
23 risks, 4 new, 1 dropped, 2 reworded since the prior year. Cash dropped to $11.9 million by December 31, 2025, increasing the need for external financing. Regulatory approvals from the FDA and global data protection compliance introduce significant new legal and financial hurdles.
Filed Mar 31, 2026 - FY2024 10-K risk factors
20 risks. The company's risk profile is dominated by going concern warnings, recurring operating losses, and a heavy reliance on third-party suppliers. Additional major risks include fierce market competition, the need for further capital, and complex regulatory compliance requirements.
Filed Mar 27, 2025